PE-22-28 Cost Per Month Budget — Pricing & Planning Guide

Research budgets fail most often at the procurement stage. Not because facilities underestimate unit costs, but because they overlook the layered expenses that compound across a protocol's lifespan. PE-22-28 (also referred to as N-acetyl-semax), a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH) fragments, demonstrates neuroprotective and cognitive enhancement properties in preclinical models. Clinical supply channels don't operate like pharmaceutical distribution. Pricing structures depend on synthesis batch size, purity verification standards, cold-chain logistics, and whether your facility sources from compounding pharmacies, research chemical suppliers, or direct synthesis labs. A facilitybudgeting $150 monthly for PE-22-28 without accounting for reconstitution supplies, refrigerated storage, and dosage titration timelines will hit procurement gaps within six weeks.

Our team has guided research institutions through peptide budgeting across hundreds of protocols in this space. The gap between accurate cost planning and budget overruns comes down to three variables most procurement guides never isolate: dose-per-administration variability, supplier tier differences in per-milligram pricing, and the hidden costs of maintaining peptide stability through the protocol window.

What does PE-22-28 cost per month for research applications?

PE-22-28 cost per month budget typically ranges from $180 to $320 depending on dose frequency, supplier pricing tier, and protocol duration. Research-grade PE-22-28 is sold as lyophilised powder in 5mg, 10mg, or 30mg vials. Unit costs range from $45 to $95 per 10mg depending on purity certification and supplier. Monthly cost depends on whether protocols use 300mcg daily (totaling 9mg monthly) or 600mcg daily (18mg monthly), with higher-dose protocols requiring multiple vials.

PE-22-28 cost per month budget isn't just the peptide itself. Facilities often budget only for the active compound while overlooking reconstitution supplies (bacteriostatic water at $12–$18 per 30mL), sterile syringes ($0.40–$0.80 each for insulin syringes), alcohol prep pads, and refrigerated storage requirements. A 30-day protocol at 300mcg daily uses one 10mg vial ($65–$85 from mid-tier suppliers like Real Peptides), plus reconstitution water, disposable syringes, and cold storage. Total monthly outlay sits closer to $95–$125 when auxiliaries are included. Doubling dose frequency to 600mcg daily pushes monthly costs to $180–$240 depending on supplier tier and whether bulk purchasing discounts apply.

Understanding PE-22-28 Procurement Channels

PE-22-28 isn't FDA-approved for human use. It exists in research supply channels as an investigational peptide compound. Three primary procurement tiers define the market: research chemical suppliers (lowest cost, minimal purity documentation), specialty peptide vendors (mid-tier pricing with HPLC certificates), and 503B compounding pharmacies (highest cost, pharmaceutical-grade synthesis). The tier you select determines both unit cost and compliance with institutional research standards. Facilities conducting NIH-funded studies or work subject to Good Laboratory Practice (GLP) oversight must source from suppliers providing third-party purity verification, which eliminates the lowest-cost tier entirely.

Research chemical suppliers price PE-22-28 at $45–$60 per 10mg but rarely provide certificates of analysis beyond vendor-generated purity claims. Specialty peptide vendors like Real Peptides occupy the mid-tier: $65–$85 per 10mg with third-party HPLC verification confirming ≥98% purity and correct amino acid sequencing. Compounding pharmacies registered as FDA 503B outsourcing facilities charge $95–$120 per 10mg but guarantee pharmaceutical-grade synthesis under USP <797> cleanroom standards. The premium reflects regulatory compliance, not superior peptide quality. For research applications without pharmaceutical-grade requirements, mid-tier suppliers deliver the cost-efficacy balance most facilities need.

Bulk purchasing introduces volume discounts that reshape monthly budgets. Ordering three 10mg vials simultaneously often reduces per-vial cost by 12–18% compared to single-vial orders. A facility running continuous 600mcg daily protocols (requiring two vials monthly) saves $22–$35 per month by ordering quarterly rather than monthly. Our experience shows that peptide degradation risk during extended storage outweighs discount benefits for facilities without −20°C laboratory freezers. Lyophilised PE-22-28 remains stable at −20°C for 24+ months but degrades within 90 days at standard refrigerator temperatures (2–8°C).

Dose-Dependent Cost Structures

PE-22-28 cost per month budget scales directly with protocol dose and administration frequency. Preclinical models use doses ranging from 50mcg to 1,000mcg per administration, with cognitive research protocols clustering around 300–600mcg once or twice daily. A 300mcg daily protocol administered subcutaneously consumes 9mg monthly (0.3mg × 30 days). Fitting entirely within one 10mg vial with 1mg remaining as loss margin for reconstitution waste and injection technique variability. At mid-tier pricing ($70 per 10mg), monthly peptide cost sits at $70 before auxiliaries.

Doubling dose to 600mcg daily increases monthly consumption to 18mg. Requiring two 10mg vials at $140 combined cost. Twice-daily administration (300mcg per dose) also totals 18mg monthly, creating identical cost structures. The critical budget inflection occurs at doses exceeding 600mcg daily. These protocols require three vials monthly, pushing base peptide costs to $210–$255 before reconstitution supplies. Facilities planning dose escalation studies must budget for peak-dose months rather than starting-dose months to avoid mid-protocol procurement gaps.

Reconstitution volume decisions affect per-administration cost through syringe precision limits. Reconstituting 10mg PE-22-28 with 2mL bacteriostatic water creates a 5mg/mL solution. Each 300mcg dose requires drawing 0.06mL. Insulin syringes measure in 0.01mL increments, making 0.06mL draws feasible but error-prone. Diluting to 1mg/mL (10mL total volume per 10mg vial) allows 0.3mL draws for 300mcg doses. More precise but consuming five times the bacteriostatic water ($12 per 30mL bottle covers six vials at 2mL per vial, but only 1.5 vials at 10mL per vial). The auxiliary cost difference is $2.40 per vial. Minor individually but accumulating to $28 annually in continuous protocols.

Hidden Costs in Peptide Protocol Budgets

Facilities budgeting only for PE-22-28 vials systematically underestimate monthly costs by 22–35%. Bacteriostatic water (0.9% benzyl alcohol in sterile water for injection) is required for reconstitution. Lyophilised peptides cannot be reconstituted with standard sterile water because the absence of bacteriostatic preservative allows bacterial growth in multi-dose vials. A 30mL bottle costs $12–$18 and reconstitutes 15 vials at 2mL per vial. Monthly cost for a two-vial protocol is $1.60–$2.40.

Insulin syringes (typically 0.3mL or 0.5mL capacity with 29G or 31G needles) cost $0.40–$0.80 each when purchased in boxes of 100. A daily administration protocol uses 30 syringes monthly at $12–$24 total cost. Alcohol prep pads add $0.05–$0.10 per use ($1.50–$3.00 monthly). These auxiliaries combine to $15–$29 monthly. Seemingly trivial but representing 18–24% of total protocol cost at 300mcg daily dosing.

Refrigerated storage introduces infrastructure costs often excluded from per-protocol budgets. Lyophilised PE-22-28 requires −20°C storage before reconstitution; once mixed with bacteriostatic water, refrigeration at 2–8°C is mandatory with 28-day use-by limits. Facilities without dedicated peptide refrigeration may need a compact laboratory refrigerator ($180–$320) or a purpose-built medication cooler for home research settings ($45–$85). These are one-time costs but must be factored into first-month budgets.

Shipping costs vary by supplier and order frequency. Peptide shipments require cold-chain logistics. Gel ice packs and insulated packaging add $8–$18 per shipment. Suppliers offering free shipping above minimum order thresholds ($150–$200) eliminate this cost for facilities ordering quarterly, but monthly orders incur it repeatedly. Temperature excursions during shipping can denature peptide structure irreversibly. Facilities in warm climates may need expedited shipping ($25–$45 surcharge) during summer months to prevent thermal degradation.

PE-22-28 Cost Per Month Budget: Supplier Comparison

| Supplier Tier | Unit Cost (10mg) | Purity Documentation | Bulk Discount | Typical Monthly Cost (300mcg daily) | Typical Monthly Cost (600mcg daily) | Professional Assessment |
|—|—|—|—|—|—|
| Research Chemical Suppliers | $45–$60 | Vendor COA only | 10–15% at 5+ vials | $50–$70 (peptide only) | $95–$125 (peptide only) | Lowest cost but insufficient documentation for GLP or institutional research. Suitable only for informal exploratory work |
| Specialty Peptide Vendors (e.g., Real Peptides) | $65–$85 | Third-party HPLC + MS | 12–18% at 3+ vials | $70–$95 (peptide + auxiliaries ~$90–$120) | $140–$180 (peptide + auxiliaries ~$170–$215) | Best cost-efficacy balance for non-pharmaceutical research. Verifiable purity at mid-tier pricing |
| 503B Compounding Pharmacies | $95–$120 | USP <797> compliance + full traceability | Rare (prescription model) | $100–$130 (peptide + auxiliaries ~$120–$160) | $200–$250 (peptide + auxiliaries ~$230–$285) | Required for pharmaceutical-grade work but cost premium rarely justified for exploratory peptide research |

What If: PE-22-28 Budget Scenarios

What If I Need to Budget for Dose Escalation Studies?

Budget to the highest planned dose rather than starting dose. A facility planning escalation from 300mcg to 900mcg daily over 12 weeks must allocate for three vials monthly ($210–$255) from week one. Mid-protocol budget requests delay timelines. Dose escalation protocols also increase auxiliary costs proportionally: 900mcg daily uses three times the syringes and alcohol pads as 300mcg daily, adding $30–$60 monthly. Calculate total monthly cost at peak dose, then multiply by protocol duration in months.

What If My Supplier Experiences a Stock Outage Mid-Protocol?

Maintain a one-month buffer inventory at all times. PE-22-28 synthesis is batch-dependent. Suppliers experience 2–6 week stock gaps when batches fail purity testing or demand exceeds production capacity. Order your next month's supply when you open your current month's first vial, not when you finish it. Lyophilised PE-22-28 stored at −20°C remains stable for 24+ months, so buffer inventory doesn't create waste risk. Our team has seen protocols derailed by three-week supplier delays that could've been avoided with basic inventory discipline.

What If I'm Comparing PE-22-28 Cost to Other Nootropic Peptides?

PE-22-28 sits mid-range in per-month nootropic peptide costs. Semax (the non-acetylated parent compound) costs $55–$75 per 10mg at similar doses but lacks PE-22-28's extended half-life, requiring more frequent administration. Selank (an anxiolytic peptide) costs $60–$80 per 10mg but protocols use 250–500mcg doses rather than 300–600mcg, making monthly consumption slightly lower. Dihexa demonstrates greater cognitive enhancement in animal models but costs $120–$180 per 5mg. More than double PE-22-28's per-milligram price. Budget selection depends on protocol goals, not cost alone.

The Unvarnished Truth About PE-22-28 Pricing

Here's the honest answer: PE-22-28 cost per month budget planning fails most often because facilities treat peptides like bulk reagents rather than biologics. You can't budget PE-22-28 the way you budget for sodium chloride or ethanol. Storage requirements, stability windows, and reconstitution protocols introduce cost layers that commodity chemical budgets ignore. A facility allocating $150 monthly without accounting for bacteriostatic water, syringes, cold storage, and dose escalation contingencies will face procurement gaps before the second month ends. The peptide itself is 65–75% of total cost. The remaining 25–35% comes from the infrastructure and consumables required to maintain peptide stability and sterility through the administration window. Facilities that budget only for vials systematically underestimate by $45–$95 monthly.

PE-22-28 cost per month budget isn't a single number. It's a range that depends on whether you're running a 300mcg daily protocol with quarterly bulk orders from a mid-tier supplier like Real Peptides ($95–$125 monthly) or a 900mcg twice-daily protocol with monthly orders from a 503B pharmacy ($320–$380 monthly). Most facilities land between $180 and $250 monthly when all variables are included. If a supplier quotes you a flat monthly cost without asking about your dose, frequency, storage capacity, and bulk purchasing capability. They're not quoting accurately. Peptide budgets require specificity. Generic estimates create procurement failures.